A study of CAP-2003 for the treatment of ocular graft-versus-host disease

Trial Profile

A study of CAP-2003 for the treatment of ocular graft-versus-host disease

Planning
Phase of Trial: Phase I

Latest Information Update: 10 Aug 2017

At a glance

  • Drugs CAP 2003 (Primary)
  • Indications Graft-versus-host disease
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Aug 2017 According to a Capricor Therapeutics media release, company plans to initiate this study in 2018.
    • 13 Sep 2016 New trial record
    • 15 Aug 2016 According to a Capricor Therapeutics media release, the company is planning to file an Investigational New Drug application for CAP-2003 for the treatment of ocular graft-versus-host disease in the first half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top